🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Human urinary kallidinogenase can promote the establishment of collateral c...
Status
Completed
Location
Department of Neurolgy,Xuanwu Hospital of Capital Medical University
Start Date
2013-01
Trial ID
NCT02259738
Treatments Being Tested
This is a randomized, double-blind, placebo-parallel-controlled multiplier ...
Status
Unknown
Location
Peking University Third Hospital
Start Date
2018-04-01
Trial ID
NCT04950790
Treatments Being Tested
Shuxuening injection is a multi-target neuroprotective agent, it is expecte...
Status
Recruiting
Location
Fangshan District First Hospital
Start Date
2024-01-11
Trial ID
NCT06157502
Treatments Being Tested
The purpose of this study is get to know what and how Shuxuening injection ...
Status
Unknown
Location
Multiple Locations
Start Date
2012-10
Trial ID
NCT01752946
Aneurysmal subarachnoid hemorrhage (SAH) is a frequent worldwide cause for ...
Status
Unknown
Location
Beijing Tiantan Hospital
Start Date
2024-01-24
Trial ID
NCT06138353
Treatments Being Tested